为银屑病国际患者中心结局集奠定基础:一项范围研究
本研究通过国际工作组(35名专家,来自22个国家)的会议和调查,修订了比利时初步提出的银屑病患者的结局集,形成18个患者相关结局和2个患者体验,并提出了50个病例组合变量,为后续国际德尔菲共识验证奠定基础。
要点
- 修订后的银屑病国际患者中心结局集包含18个患者相关结局和2个患者体验。
- 基于患者建议新增「污名感」和「发作次数」两个结局。
- 下一步将通过国际德尔菲共识过程最终确定该结局集。
核心结论
- 国际工作组修订形成了包含18个患者相关结局和2个患者体验的银屑病患者中心结局集。
研究设计与样本
- 范围研究:通过国际银屑病协会联合会和国际银屑病理事会建立国际工作组,包含12名患者代表和23名皮肤科医生,来自22个国家。
主要发现
- 工作组通过三次讨论会议和两次后续调查修订结局集。
- 「可接受的社会护理成本」被排除;四个结局合并为「银屑病清除」和「社交活动」;「沟通」和「护理信心」重新分类为患者体验。
- 基于患者建议新增「污名感」和「发作次数」。
- 最终形成18个患者相关结局和2个患者体验,并基于文献和专家意见提出50个病例组合变量。
关键数值与推荐
- 结局测量工具根据COSMIN标准选择,并绘制热图评估重叠、质量和可行性。
临床怎么用
- 该结局集经后续德尔菲共识最终确定后,可用于指导银屑病价值医疗管理,聚焦患者真正关心的结局。
局限性
- 当前为范围研究阶段,结局集尚未经过国际德尔菲共识最终验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Value-based healthcare emphasizes outcomes that matter to patients, and patient-centred outcomes sets are vital to its success. For psoriasis, initial work proposed a patient-centred outcomes set in Belgium, but it requires further validation to ensure international applicability. OBJECTIVES: This scoping study aimed to refine the outcomes set in collaboration with patient representatives and dermatologists, in preparation for international validation through a Delphi consensus process. METHODS: An international Working Group of patient representatives and dermatologists was established through the International Federation for Psoriasis Associations (IFPA) and the International Psoriasis Council (IPC). Experts participated in three discussion meetings and subsequent surveys to discuss and recommend outcomes important to people living with psoriasis, their measurement and case-mix variables. The systematic review of patient-relevant outcomes was updated as well and outcome measurement instruments were selected corresponding to the COSMIN criteria. RESULTS: The Working Group included 35 experts (12 patient representatives and 23 dermatologists) from 22 countries. A total of three discussion meetings and two subsequent surveys informed the refinement of the outcomes set. 'Acceptable costs of care for society' was excluded as an outcome, four outcomes were merged into 'psoriasis clearance' and 'social activity', and 'communication' and 'confidence in care' were reclassified as patient experiences. 'Feelings of stigmatization' and 'number of flare-ups' were added based on patient recommendations. These changes resulted in a revised set of 18 patient-relevant outcomes and 2 patient experiences. After selecting outcome measurement instruments, a heatmap was compiled to assess overlap, quality and feasibility. Finally, 50 case-mix variables were proposed based on the literature and expert opinions. CONCLUSIONS: This scoping study convened an international Working Group of patient representatives and dermatologists to establish the fundamentals for a patient-centred outcomes set. The subsequent Delphi process will finalize consensus, advancing value-based psoriasis management worldwide. People living with psoriasis often experience more than just skin symptoms; the disease can affect their daily life, emotional well‐being and other health problems, including comorbidities. To improve psoriasis management, doctors and patients need to agree on what outcomes matter most and how to measure them. This study is part of a larger international project that aims to develop a patient‐centred outcomes set for psoriasis, meaning a list of outcomes that reflect patients’ real priorities. This international project consists of three phases. In the initial phase, the project team first reviewed the literature and worked with Belgian patients to create an initial set of 21 patient‐relevant outcomes. To make this list useful, relevant and applicable internationally, we then brought together 35 experts, including 12 patient representatives and 23 dermatologists from 22 countries, for online meetings and surveys during the scoping phase. Together, the experts reviewed and refined the outcomes and their definitions, outcome measurement instruments and factors that can influence patient outcomes (i.e. case‐mix variables). As a result, the group proposed a revised set of 18 patient‐relevant outcomes and 2 patient experiences. The final phase will be an international Delphi study, in which a larger group of experts will vote to reach final agreement. Once validated and implemented, this patient‐centred outcomes set will help patients and clinicians worldwide to focus on what truly matters in psoriasis care, improving quality of life, achieving better outcomes and supporting personalized management for people living with psoriasis.
引用
- Vyvey E, Soenen R, Oon HH, et al. Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping study. J Eur Acad Dermatol Venereol. 2026. PMID: 41641893. doi:10.1111/jdv.70313
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。